416 related articles for article (PubMed ID: 17977517)
1. The behavioral pharmacology of hallucinogens.
Fantegrossi WE; Murnane KS; Reissig CJ
Biochem Pharmacol; 2008 Jan; 75(1):17-33. PubMed ID: 17977517
[TBL] [Abstract][Full Text] [Related]
2. A common mechanism for lysergic acid, indolealkylamine and phenethylamine hallucinogens: serotonergic medication of behavioral effects in rats.
Sloviter RS; Drust EG; Damiano BP; Connor JD
J Pharmacol Exp Ther; 1980 Aug; 214(2):231-8. PubMed ID: 6104720
[No Abstract] [Full Text] [Related]
3. Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.
Winter JC
Psychopharmacology (Berl); 2009 Apr; 203(2):251-63. PubMed ID: 18979087
[TBL] [Abstract][Full Text] [Related]
4. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
Glennon RA; Rosecrans JA
Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity-relationships of certain hallucinogenic substances based on brain levels.
Vogel WH; Evans BD
Life Sci; 1977 May; 20(10):1629-35. PubMed ID: 69244
[No Abstract] [Full Text] [Related]
6. Structure-activity relationships in potentially hallucinogenic N,N-dialkyltryptamines substituted in the benzene moiety.
Kline TB; Benington F; Morin RD; Beaton JM
J Med Chem; 1982 Aug; 25(8):908-13. PubMed ID: 7120280
[TBL] [Abstract][Full Text] [Related]
7. Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination procedures.
Appel JB; White FJ; Holohean AM
Neurosci Biobehav Rev; 1982; 6(4):529-36. PubMed ID: 7177512
[TBL] [Abstract][Full Text] [Related]
8. Hallucinogens as discriminative stimuli.
Winter JC
Fed Proc; 1974 Jul; 33(7):1825-32. PubMed ID: 4209212
[No Abstract] [Full Text] [Related]
9. Psychotomimetic drugs: biochemistry and pharmacology.
Brimblecombe RW
Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
[No Abstract] [Full Text] [Related]
10. Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.
Monte AP; Marona-Lewicka D; Lewis MM; Mailman RB; Wainscott DB; Nelson DL; Nichols DE
J Med Chem; 1998 Jun; 41(12):2134-45. PubMed ID: 9622555
[TBL] [Abstract][Full Text] [Related]
11. Speculations on the mechanism of action of hallucinogenic indolealkylamines.
Glennon RA; Rosecrans JA
Neurosci Biobehav Rev; 1981; 5(2):197-207. PubMed ID: 7022271
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.
Halberstadt AL
Behav Brain Res; 2015 Jan; 277():99-120. PubMed ID: 25036425
[TBL] [Abstract][Full Text] [Related]
13. A relationship between the hallucinogenic activity of drugs and their electronic configuration.
Snyder SH; Merril CR
Proc Natl Acad Sci U S A; 1965 Jul; 54(1):258-66. PubMed ID: 5216361
[No Abstract] [Full Text] [Related]
14. Stimulus properties of phenethylamine hallucinogens and lysergic acid diethylamide: the role of 5-hydroxytryptamine.
Winter JC
J Pharmacol Exp Ther; 1978 Feb; 204(2):416-23. PubMed ID: 621672
[No Abstract] [Full Text] [Related]
15. Chronic phenethylamine hallucinogen treatment alters behavioral sensitivity to a metabotropic glutamate 2/3 receptor agonist.
Benneyworth MA; Smith RL; Sanders-Bush E
Neuropsychopharmacology; 2008 Aug; 33(9):2206-16. PubMed ID: 17957214
[TBL] [Abstract][Full Text] [Related]
16. Some behavioral effects of hallucinogens are mediated by a postsynaptic serotonergic action: evidence from single unit studies in freely moving cats.
Heym J; Rasmussen K; Jacobs BL
Eur J Pharmacol; 1984 May; 101(1-2):57-68. PubMed ID: 6745319
[TBL] [Abstract][Full Text] [Related]
17. Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
Smith DA; Bailey JM; Williams D; Fantegrossi WE
J Pharmacol Exp Ther; 2014 Dec; 351(3):485-91. PubMed ID: 25271256
[TBL] [Abstract][Full Text] [Related]
18. Hallucinogens and Drosophila: linking serotonin receptor activation to behavior.
Nichols CD; Ronesi J; Pratt W; Sanders-Bush E
Neuroscience; 2002; 115(3):979-84. PubMed ID: 12435434
[TBL] [Abstract][Full Text] [Related]
19. The use of drug discrimination procedures to characterize hallucinogenic drug actions.
Appel JB; Cunningham KA
Psychopharmacol Bull; 1986; 22(3):959-67. PubMed ID: 3797596
[No Abstract] [Full Text] [Related]
20. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
McLean TH; Parrish JC; Braden MR; Marona-Lewicka D; Gallardo-Godoy A; Nichols DE
J Med Chem; 2006 Sep; 49(19):5794-803. PubMed ID: 16970404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
